T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Weyerhaeuser
WY
$18B
| $1.46B | 0.31% |
40,792,083
-4,183,341
| -9% | -$144M |
|
77
Agilent Technologies
A
$42.2B
| $1.45B | 0.31% |
35,472,940
-10,824,009
| -23% | -$437M |
|
78
Texas Instruments
TXN
$257B
| $1.44B | 0.31% |
27,006,951
-1,117,709
| -4% | -$56.5M |
|
79
PG&E
PCG
$38.1B
| $1.44B | 0.31% |
27,102,127
-4,933,916
| -15% | -$244M |
|
80
Aptiv
APTV
$10.3B
| $1.44B | 0.31% |
19,819,322
+437,734
| +2% | +$30.2M |
|
81
Tractor Supply
TSCO
$18.4B
| $1.44B | 0.3% |
91,044,970
-2,855,995
| -3% | -$40.9M |
|
82
MetLife
MET
$61.5B
| $1.43B | 0.3% |
29,609,950
+1,757,674
| +6% | +$83.5M |
|
83
Vipshop
VIPS
$7.2B
| $1.43B | 0.3% |
72,981,935
+8,099,365
| +12% | +$171M |
|
84
Carnival Corporation Ltd
CCL
$38B
| $1.42B | 0.3% |
31,279,418
+1,389,473
| +5% | +$56.8M |
|
|
KSU
85
DELISTED
Kansas City Southern
KSU
| $1.41B | 0.3% |
11,524,813
-113,163
| -1% | -$13.5M |
|
86
Textron
TXT
$15.2B
| $1.4B | 0.3% |
33,347,738
-2,006,419
| -6% | -$80.5M |
|
87
Vulcan Materials
VMC
$37.3B
| $1.39B | 0.3% |
21,133,868
+3,448,099
| +19% | +$218M |
|
88
Philip Morris
PM
$290B
| $1.37B | 0.29% |
16,845,830
-1,690,959
| -9% | -$145M |
|
89
MGM Resorts International
MGM
$11.1B
| $1.37B | 0.29% |
64,123,305
+15,499,220
| +32% | +$337M |
|
90
US Bancorp
USB
$100B
| $1.36B | 0.29% |
30,275,700
-1,640,582
| -5% | -$70.6M |
|
|
HBI
91
DELISTED
Hanesbrands
HBI
| $1.36B | 0.29% |
48,564,516
+11,197,728
| +30% | +$307M |
|
|
92
Becton Dickinson
BDX
$49.4B
| $1.35B | 0.29% |
9,927,706
+5,744,663
| +137% | +$735M |
|
93
Tesla
TSLA
$1.31T
| $1.33B | 0.28% |
89,849,145
+33,573,540
| +60% | +$525M |
|
94
Humana
HUM
$44.8B
| $1.32B | 0.28% |
9,183,654
+211,193
| +2% | +$28.9M |
|
|
HSP
95
DELISTED
HOSPIRA INC
HSP
| $1.31B | 0.28% |
21,442,043
-788,143
| -4% | -$44.5M |
|
96
JB Hunt Transport Services
JBHT
$24.9B
| $1.24B | 0.26% |
14,725,720
+2,986,764
| +25% | +$238M |
|
97
AT&T
T
$168B
| $1.23B | 0.26% |
48,664,234
-4,805,616
| -9% | -$125M |
|
|
PCYC
98
DELISTED
PHARMACYCLICS INC
PCYC
| $1.21B | 0.26% |
9,886,484
+60,592
| +0.6% | +$7.74M |
|
99
PNC Financial Services
PNC
$101B
| $1.17B | 0.25% |
12,855,187
-770,477
| -6% | -$66.8M |
|
100
Wabtec
WAB
$50.3B
| $1.17B | 0.25% |
13,464,332
+2,235,948
| +20% | +$188M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.